Use of carbidopa along with levodopa in the treatment
of parkinsonism:
A. Inhibits development of involuntary movements
B. Minimises ‘on-off ’ effect’
C. Inhibits occurrence of behavioral abnormalities
D. Accentuates nausea and vomiting
of parkinsonism:
A. Inhibits development of involuntary movements
B. Minimises ‘on-off ’ effect’
C. Inhibits occurrence of behavioral abnormalities
D. Accentuates nausea and vomiting